Statements (30)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:cancer
Lymphoma |
gptkbp:affects |
Adults
Immunocompromised individuals |
gptkbp:alsoKnownAs |
gptkb:Body_cavity–based_lymphoma
|
gptkbp:associatedVirus |
Epstein-Barr virus (sometimes)
|
gptkbp:associatedWith |
gptkb:Human_herpesvirus_8
HIV infection Immunosuppression |
gptkbp:cellOrigin |
gptkb:B_cell
|
gptkbp:characterizedBy |
Malignant effusions in body cavities
|
gptkbp:diseaseOf |
Lymphatic system
|
gptkbp:firstDescribed |
1996
|
gptkbp:frequency |
Rare
|
gptkbp:hasImmunophenotype |
CD30 positive
CD138 positive CD20 negative CD45 positive |
https://www.w3.org/2000/01/rdf-schema#label |
Primary effusion lymphoma
|
gptkbp:ICD-10_code |
C85.8
|
gptkbp:mortalityRate |
High
|
gptkbp:prognosis |
Poor
|
gptkbp:rarelyForms |
Solid tumor masses
|
gptkbp:treatment |
Chemotherapy
Antiretroviral therapy |
gptkbp:website |
gptkb:Pericardial_cavity
gptkb:Pleural_cavity gptkb:Peritoneal_cavity |
gptkbp:bfsParent |
gptkb:KSHV
|
gptkbp:bfsLayer |
7
|